Company / Assets per Share
Protalix BioTherapeutics, Inc. Assets per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$1.09
FY2025
5-year range
$1.01 / $2.12
FY2021-FY2025
Trend
+7.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has fluctuated over the past 10 years, ranging from $0.58 in FY2017 to $4.58 in FY2020.
Based on SEC 10-K filings.
1.09 in FY2025 with a 10-year CAGR of +0.4%.
Declined from $1.57 to $1.09 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -3.9%
- 5-Year CAGR
- -25.0%
- 10-Year CAGR
- +0.4%
Key checks
Key Insights
- In FY2025, assets per share increased 7.9% year-over-year.
- Peak assets per share was recorded in FY2020.
- Lowest assets per share in the period was in FY2017.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.09 | +7.9% |
| FY2024 | $1.01 | -35.9% |
| FY2023 | $1.57 | +28.2% |
| FY2022 | $1.22 | -42.2% |
| FY2021 | $2.12 | -53.7% |
| FY2020 | $4.58 | +49.7% |
| FY2019 | $3.06 | +425.9% |
| FY2017 | $0.58 | -29.4% |
| FY2016 | $0.82 | -20.7% |
| FY2015 | $1.04 | +23.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026